Regulation of antigen-induced human T-lymphocyte responses by calcineurin antagonists

Citation
Se. Pacocha et al., Regulation of antigen-induced human T-lymphocyte responses by calcineurin antagonists, J ALLERG CL, 104(4), 1999, pp. 828-835
Citations number
32
Categorie Soggetti
Clinical Immunolgy & Infectious Disease",Immunology
Journal title
JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY
ISSN journal
00916749 → ACNP
Volume
104
Issue
4
Year of publication
1999
Part
1
Pages
828 - 835
Database
ISI
SICI code
0091-6749(199910)104:4<828:ROAHTR>2.0.ZU;2-#
Abstract
Background: Cyclosporin A (CS) and tacrolimus (FK506, FK) are calcineurin a ntagonists used widely as T-cell immunosuppressants: however, their relativ e efficacy on antigen-stimulated T-cell subsets remains undefined. Objective: We have examined the effects of CS and FK on antigen-driven prol iferation and cytokine generation from human PBMCs and T-cell clones, Methods: Proliferation was assessed by tritiated thymidine incorporation. C ytokine generation was assessed by reverse transcription-PCR and ELISA, Results: Ragweed- and tetanus toroid-driven proliferation of PBMCs was down -regulated equally by CS or FK, Gene expression for proinflammatory cytokin es (IL-I, IL-5, IL-13, and IFN-gamma) assessed by reverse transcription-PCR was down-regulated in a concentration-dependent manner by either drug. Ant igen-induced proliferation of ragweed-specific Th0, Th1, or Th2 clones was inhibited by either CS or FK. Cytokine gene expression and protein secretio n into culture supernatants (IL-4, IL-5, IL-13, and IFN-gamma) were down-re gulated in a concentration-dependent manner by either CS or FK in all relev ant T-cell subsets. Interestingly, down-regulation of IL-5 protein generati on from Th0 and Th2 clones was consistently less sensitive to either drug t han was the effect on either IL-4 or IL-13 protein generation, Conclusion: CS and FK promote equivalent down-regulation of Th0, Th1, and T h2 responses; how ever, IL-5 generation is relatively insensitive to the im munomodulatory effects of calcineurin antagonists.